{"id":"W4402558405","doi":"10.1016/j.annonc.2024.08.1346","title":"1289P Pooled efficacy and safety from 2 pivotal phase II trials of taletrectinib in patients (Pts) with advanced or metastatic ROS1+ non-small cell lung cancer (NSCLC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; ROS1; Oncology; Internal medicine; Lung cancer; Phases of clinical research; Clinical trial; Safety profile; Cancer; Adenocarcinoma; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002572187,0.001116016,0.002197791,0.0004548107,0.0001769509,0.001135927,0.0004391889,0.000829283,0.00441469],"category_scores_gemma":[0.002316802,0.0004393863,0.004423428,0.0005999583,0.000413749,0.0009044476,0.0005337053,0.001994204,0.0007225499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007637391,"about_ca_system_score_gemma":0.0007014861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008200669,"about_ca_topic_score_gemma":0.002448018,"domain_scores_codex":[0.9991923,0.0004193026,0.00006839262,0.000135968,0.0000883609,0.00009562559],"domain_scores_gemma":[0.9993041,0.0002251942,0.0001814905,0.00006365036,0.00008489656,0.0001406099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8162209,0.001398664,0.008845767,0.001944397,0.02691432,0.0001300244,0.00007519062,0.004042814,0.01271782,0.0003003323,0.009125583,0.118284],"study_design_scores_gemma":[0.7619714,0.1139563,0.06089171,0.0003250768,0.04052938,0.0005047352,0.0001229673,0.003204084,0.004146278,0.001104036,0.01310795,0.0001361958],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9564331,0.01968852,0.001676887,0.001980914,0.000569515,0.001170623,0.009871016,0.0002035708,0.008405961],"genre_scores_gemma":[0.9828772,0.00457408,0.0007693064,0.001170695,0.0002666015,0.0005127179,0.006821884,0.0000494645,0.002958167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00441469,"threshold_uncertainty_score":0.01476854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0491402154988023,"score_gpt":0.4385308151696402,"score_spread":0.3893905996708379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}